- Home
- SCLX vs AITR Comparison
SCLX vs AITR Comparison
Compare SCLX & AITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- AITR
- Stock Information
- Founded
- SCLX 2011
- AITR 2022
- Country
- SCLX United States
- AITR United States
- Employees
- SCLX N/A
- AITR N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- AITR
- Sector
- SCLX Health Care
- AITR
- Exchange
- SCLX Nasdaq
- AITR Nasdaq
- Market Cap
- SCLX 81.7M
- AITR 83.1M
- IPO Year
- SCLX N/A
- AITR 2023
- Fundamental
- Price
- SCLX $0.42
- AITR $10.74
- Analyst Decision
- SCLX Strong Buy
- AITR
- Analyst Count
- SCLX 3
- AITR 0
- Target Price
- SCLX $11.33
- AITR N/A
- AVG Volume (30 Days)
- SCLX 184.3K
- AITR 17.0K
- Earning Date
- SCLX 01-07-2025
- AITR 01-01-0001
- Dividend Yield
- SCLX N/A
- AITR N/A
- EPS Growth
- SCLX N/A
- AITR N/A
- EPS
- SCLX N/A
- AITR 0.24
- Revenue
- SCLX $50,833,000.00
- AITR N/A
- Revenue This Year
- SCLX $32.77
- AITR N/A
- Revenue Next Year
- SCLX $50.71
- AITR N/A
- P/E Ratio
- SCLX N/A
- AITR $45.40
- Revenue Growth
- SCLX 9.41
- AITR N/A
- 52 Week Low
- SCLX $0.40
- AITR $10.11
- 52 Week High
- SCLX $2.63
- AITR $10.75
- Technical
- Relative Strength Index (RSI)
- SCLX 29.75
- AITR 79.99
- Support Level
- SCLX $0.43
- AITR $10.68
- Resistance Level
- SCLX $0.51
- AITR $10.75
- Average True Range (ATR)
- SCLX 0.06
- AITR 0.01
- MACD
- SCLX -0.01
- AITR 0.00
- Stochastic Oscillator
- SCLX 7.30
- AITR 88.89
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About AITR AI TRANSPORTATION ACQUISITION CORP Ordinary shares
AI Transportation Acquisition Corp is a blank check company.